JZ

Johannes Zanzinger

Boehringer Ingelheim Venture Fund

Ulm, Baden-Württemberg

Invests in

Stages:

Locations:

  • Min Investment:

    $3,250,000.00
  • Max Investment:

    $17,000,000.00
  • Target Investment:

    $8,500,000.00

Education

Work Experience

  • Professor (apl) of Physiology

    2011

  • Member Board Of Directors

    2022

2020

  • Member Board Of Directors

    2020

  • Member Board Of Directors

    2019

  • Investor @ BI Venture Fund

    2019

  • Global Head, Business Development & Licensing CardioMetabolic Diseases

    2009 - 2019

  • Head, Licensing Metabolic Diseases

    2005 - 2009

  • Senior Principal Scientist, R&D Coordination

    2002 - 2005

2021 - 2023

  • Board Observer

    2021 - 2023

2019 - 2023

  • Member Board Of Directors

    2019 - 2023

2020 - 2021

  • Member Board Of Directors

    2020 - 2021

1999 - 2002

  • Senior Principle Scientist

    1999 - 2002

    Discovery Research, in vivo Pharmacology

  • Associate Professor of Physiology

    1993 - 1999